Scigen Pteltdis A Biopharmaceutical Company Based In Singaporeestablished In 1988It Specializes In Developingmanufacturingand Commercializing Biosimilar And Innovative Healthcare Productswith A Presence Across Six Continentsscigen Has Subsidiaries In Australiachinasouth Koreaand The Philippinesand It Focuses On Areas Such As Endocrinologyoncologyand Immunologyaddressing Diseases Like Diabetes And Cancer The Company Provides Comprehensive Servicesincluding Biopharmaceutical Development Using Bacterial And Mammalian Cell Technologiesmanufacturing Of Biosimilars And Branded Pharmaceuticalsand Global Commercialization Through A Strong Sales Networkscigen Also Offers Regulatory Support To Help Secure Health Registrations And Ensure Compliance In Various Marketskey Products Include Gensulinascilinafor Diabetes Managementscitropin Aafor Endocrine Disordersand Zometaafor Oncology Related Bone Complicationsalong With Other Biosimilars And A Hepatitis B Vaccine
